Literature DB >> 29232262

Intermittent versus continuous feeding in critically ill adults.

Jayshil J Patel1, Martin D Rosenthal2, Daren K Heyland3.   

Abstract

PURPOSE OF REVIEW: Early enteral nutrition is recommended in critically ill adult patients. The optimal method of administering enteral nutrition remains unknown. Continuous enteral nutrition administration in critically ill patients remains the most common practice worldwide; however, its practice has recently been called into question in favor of intermittent enteral nutrition administration, where volume is infused multiple times per day. This review will outline the key differences between continuous and intermittent enteral nutrition, describe the metabolic responses to continuous and intermittent enteral nutrition administration and outline recent studies comparing continuous with intermittent enteral nutrition administration on outcomes in critically ill adults. RECENT
FINDINGS: In separate studies, healthy humans and critically ill patients receiving intermittent nutrition (infused over 3 h) had improved whole body protein balance from negative to positive. These studies did not have an isonitrogenous control group. A randomized controlled trial of intermittent bolus versus continuous enteral nutrition in healthy humans found that intermittent bolus feeding increased mesenteric arterial blood flow, increased insulin and peptide YY and reduced blood glucose concentration. A randomized controlled trial comparing intermittent bolus to continuous enteral nutrition in critically ill patients did not demonstrate clinically relevant differences in glycemic variability, insulin use or tube feeding volume or caloric intake between the two groups.
SUMMARY: Studies in healthy humans suggest that intermittent nutrient administration, as opposed to continuous, improves whole body protein synthesis. Unfortunately, similarly designed studies are lacking for critically ill patients. Future studies evaluating the impact of intermittent versus continuous nutrition administration on critical care outcomes should take into account factors such as protein quantity, protein quality and delivery route (enteral and/or parenteral). Until further studies are conducted in critically ill patients, a recommendation for or against intermittent nutrition delivery cannot be made.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29232262     DOI: 10.1097/MCO.0000000000000447

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  7 in total

1.  Effects of synbiotic supplementation on energy and macronutrients homeostasis and muscle wasting of critical care patients: study protocol and a review of previous studies.

Authors:  Najmeh Seifi; Mohammad Safarian; Mohsen Nematy; Reza Rezvani; Majid Khadem-Rezaian; Alireza Sedaghat
Journal:  Trials       Date:  2020-02-24       Impact factor: 2.279

2.  Nutrition in critically ill patients with COVID-19: Challenges and special considerations.

Authors:  Nicole Arkin; Kumar Krishnan; Marvin G Chang; Edward A Bittner
Journal:  Clin Nutr       Date:  2020-05-15       Impact factor: 7.324

3.  Comparison of continuous versus intermittent enteral nutrition in critically ill patients (COINN): study protocol for a randomized comparative effectiveness trial.

Authors:  Ondrej Hrdy; Kamil Vrbica; Eva Strazevska; Petr Suk; Lenka Souckova; Radka Stepanova; Igor Sas; Roman Gal
Journal:  Trials       Date:  2020-11-23       Impact factor: 2.279

4.  Glucose variability during the early course of acute pancreatitis predicts two-year probability of new-onset diabetes: A prospective longitudinal cohort study.

Authors:  Sakina H Bharmal; Jaelim Cho; Juyeon Ko; Maxim S Petrov
Journal:  United European Gastroenterol J       Date:  2022-02-20       Impact factor: 4.623

Review 5.  Serotonin-Its Synthesis and Roles in the Healthy and the Critically Ill.

Authors:  Marcela Kanova; Pavel Kohout
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

6.  Protein delivery in intermittent and continuous enteral nutrition with a protein-rich formula in critically ill patients-a protocol for the prospective randomized controlled proof-of-concept Protein Bolus Nutrition (Pro BoNo) study.

Authors:  Simona Reinhold; Desirée Yeginsoy; Alexa Hollinger; Atanas Todorov; Lionel Tintignac; Michael Sinnreich; Caroline Kiss; Caroline E Gebhard; Balázs Kovács; Bianca Gysi; Lara Imwinkelried; Martin Siegemund
Journal:  Trials       Date:  2020-08-25       Impact factor: 2.279

7.  Continuous versus Intermittent Enteral Tube Feeding for Critically Ill Patients: A Prospective, Randomized Controlled Trial.

Authors:  Hong-Yeul Lee; Jung-Kyu Lee; Hye-Jin Kim; Dal-Lae Ju; Sang-Min Lee; Jinwoo Lee
Journal:  Nutrients       Date:  2022-02-04       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.